Skip to main content

Table 1 Descriptive statistics for the ICU and non-ICU samples analysed within this study

From: Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios

 

Level/unit

ICU

Non-ICU

 

Overall

Death: no

Death: yes

p

Overall

Death: no

Death: yes

p

N

 

1719 (100%)

1139 (66,3%)

580 (33.7%)

 

7474 (100%)

6849 (91.6%)

625 (8.4%)

 

Study

FROG

1719 (100%)

1139 (100%)

580 (100%)

    

 < 0.001

 

CAD Predictions

    

145 (1.9%)

50 (0.7%)

95 (15%)

 
 

CardioRen

    

116 (1.6%)

87 (1.3%)

29 (4.6%)

 
 

DIRECT

    

1,487 (20%)

1,448 (21%)

39 (6.2%)

 
 

EPOGH

    

914 (12%)

850 (12%)

64 (10%)

 
 

EU Priority

    

1769 (24%)

1756 (26%)

13 (2.1%)

 
 

GenScot

    

473 (6.3%)

417 (6.1%)

56 (9.0%)

 
 

Heart Failure

    

84 (1.1%)

67 (1.0%)

17 (2.7%)

 
 

Homage Fibrosis

    

354 (4.7%)

229 (3.3%)

125 (20%)

 
 

PersTIgAN

    

270 (3.6%)

265 (3.9%)

5 (0.8%)

 
 

Predictions

    

91 (1.2%)

85 (1.2%)

6 (1.0%)

 
 

PROPHET

    

462 (6.2%)

444 (6.5%)

18 (2.9%)

 
 

STOP IgAN

    

109 (1.5%)

107 (1.6%)

2 (0.3%)

 
 

Sun Makro

    

581 (7.8%)

556 (8.1%)

25 (4.0%)

 
 

TransBioBC

    

131 (1.8%)

117 (1.7%)

14 (2.2%)

 
 

UZ Gent

    

488 (6.5%)

371 (5.4%)

117 (19%)

 

Age

[yrs]

62 (50, 73)

58 (46, 69)

70 (61, 78)

 < 0.001

60 (48, 68)

59 (47, 66)

73 (66, 79)

 < 0.001

Female

Yes

602 (35%)

414 (36%)

188 (32%)

0.11

2,857 (38%)

2,657 (39%)

200 (32%)

 < 0.001

BMI

[kg/m2]

26.2 (22.9, 30.0)

26.2 (22.8, 29.9)

26.4 (23.1, 30.1)

0.6

27.5 (24.3, 31.2)

27.6 (24.3, 31.4)

26.9 (23.7, 30.1)

 < 0.001

Systolic BP

[mmHg]

123 (109, 140)

124 (110, 140)

120 (107, 139)

0.01

132 (121, 145)

132 (121, 144)

138 (124, 153)

 < 0.001

Diastolic BP

[mmHg]

64 (55, 75)

66 (56, 77)

60 (52, 70)

 < 0.001

79 (72, 85)

79 (73, 85)

75 (67, 82)

 < 0.001

Mean Arterial BP

[mmHg]

84 (74, 95)

86 (76, 96)

80 (71, 92)

 < 0.001

97 (90, 104)

97 (90, 104)

97 (88, 105)

0.3

Hypertension

Yes

979 (57%)

602 (53%)

377 (65%)

 < 0.001

3090 (41%)

2758 (40%)

332 (53%)

 < 0.001

eGFR

[ml/min/1.73 m2]

87 (48, 127)

97 (57, 132)

67 (37, 107)

 < 0.001

82 (59, 99)

84 (62, 100)

61 (37, 80)

 < 0.001

Kidney Disease

Yes

716 (42%)

378 (33%)

338 (58%)

 < 0.001

2212 (30%)

1898 (28%)

314 (50%)

 < 0.001

Diabetes

Yes

280 (16%)

160 (14%)

120 (21%)

 < 0.001

4101 (55%)

3938 (57%)

163 (26%)

 < 0.001

Cardiovascular Disease

Yes

98 (5.7%)

49 (4.3%)

49 (8.4%)

 < 0.001

1357 (18%)

983 (14%)

374 (60%)

 < 0.001

COV50

 

1.17 (0.34, 1.83)

1.01 (0.11, 1.74)

1.45 (0.72, 1.97)

 < 0.001

− 1.88 (− 2.33, − 1.27)

− 1.89 (− 2.34, − 1.30)

− 1.69 (− 2.26, − 0.94)

 < 0.001

FU Duration

[month]

12.0 (2.0, 12.1)

12.0 (12.0, 12.5)

0.7 (0.3, 2.1)

 < 0.001

47 (29, 67)

48 (29, 67)

38 (19, 62)

 < 0.001

  1. Categorical variables are described with absolute (N) and group-wise relative frequencies (%), continuous variables with median (IQR). P-values for group differences result from chi-squared homogeneity tests for categorical and for Wilcoxon rank sum test for continuous variables
  2. BMI body mass index, BP blood pressure, eGFR estimated glomerular filtration rate, FU follow-up, ICU intensive care unit, yrs years
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us